Intelligent bio solutions to participate in the noble capital markets' 20th annual emerging growth equity conference

New york, nov. 21, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming noble capital markets' 20th annual emerging growth equity conference on december 3-4, 2024, in boca raton, fl.
INBS Ratings Summary
INBS Quant Ranking